Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117436) titled 'Risk Factors for Cancer Therapy-Related Cardiovascular Toxicity in Breast Cancer Patients' on Jan. 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai General Hospital
Condition:
Cancer therapy-related cardiovascular toxicity in breast cancer
Intervention:
Cardiotoxicity Occurrence Group:None
Recruitment Status: Recruiting
Phase: Retrospective study
Date of First Enrollment: 2025-12-16
Target Sample Size: Cardiotoxicity Occurrence Group:110;Cardiotoxicity Non-occurrence Group:990;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...